Cargando…

Characterization of a novel mCH3 conjugated anti-PcrV scFv molecule

Pseudomonas aeruginosa (PA) is a leading cause of nosocomial infections and death in cystic fibrosis patients. The study was conducted to evaluate the physicochemical structure, biological activity and serum stability of a recombinant anti-PcrV single chain variable antibody fragment genetically att...

Descripción completa

Detalles Bibliográficos
Autores principales:	Komijani, Samira, Bayat, Elham, Rismani, Elham, Hosseini, Soma, Moazzami, Reza, Nematollahi, Leila, Sardari, Soroush, Talebkhan, Yeganeh, Davami, Fatemeh, Barkhordari, Farzaneh, Hosseini, Fakhrisadat, Jahandar, Hoda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010009/ https://www.ncbi.nlm.nih.gov/pubmed/33785781 http://dx.doi.org/10.1038/s41598-021-86491-w

Ejemplares similares

Production of an Antibody Fragment (scFv) Targeting PcrV Protein of Pseudomonas aeruginosa in Fed-Batch Cultivation Mode
por: Karam, Saba, et al.
Publicado: (2021)

Recombinant anti-human epidermal growth factor receptor type 2 single-chain variable fragment-alpha-luffin fusion protein as a putative immunotoxin against human epidermal growth factor receptor type 2-positive breast cancer cells: an experimental research
por: Damough, Shadi, et al.
Publicado: (2023)

Improvement of Certolizumab Fab′ properties by PASylation technology
por: Mazaheri, Somayeh, et al.
Publicado: (2020)

Extension of human GCSF serum half-life by the fusion of albumin binding domain
por: Nikravesh, Fatemeh Yadavar, et al.
Publicado: (2022)

Optimization of EnBase Fed-Batch Cultivation to Improve Soluble Fraction Ratio of α-Luffin Ribosome Inactivating Protein
por: Barkhordari, Farzaneh, et al.
Publicado: (2018)

Identification of Potent CD19 scFv for CAR T Cells through scFv Screening with NK/T-Cell Line
por: Kang, Chung Hyo, et al.
Publicado: (2020)

scFv Antibody: Principles and Clinical Application
por: Ahmad, Zuhaida Asra, et al.
Publicado: (2012)

Optimization of Tris/EDTA/Sucrose (TES) periplasmic extraction for the recovery of functional scFv antibodies
por: Ghamghami, Elham, et al.
Publicado: (2020)

Nonspecificity in a nonimmune human scFv repertoire
por: Kelly, Ryan L., et al.
Publicado: (2017)

“Stapling” scFv for multispecific biotherapeutics of superior properties
por: Boucher, Lauren E., et al.
Publicado: (2023)

Isolation and characterization of human anti-CD20 single-chain variable fragment (scFv) from a Naive human scFv library
por: Shams, Nasir, et al.
Publicado: (2022)

Implementation of a Design of Experiments to Improve Periplasmic Yield of Functional ScFv Antibodies in a Phage Display Platform
por: Aghdam, Marjan Abri, et al.
Publicado: (2022)

Woodchuck Hepatitis Virus Post-Transcriptional Regulation Element (WPRE) Promotes Anti-CD19 BiTE Expression in Expi293 Cells
por: Moazzami, Reza, et al.
Publicado: (2021)

The effects of N-terminal insertion into VSV-G of an scFv peptide
por: Dreja, Hanna, et al.
Publicado: (2006)

Empowering scFv with effector cell functions for improved anticancer therapeutics
por: Zhang, Hongtao
Publicado: (2013)

Integrating scFv into xMAP Assays for the Detection of Marine Toxins
por: Shriver-Lake, Lisa C., et al.
Publicado: (2016)

The Four-State Equilibrium Unfolding of a scFv Antibody Fragment
por: Pedroso, Idolka, et al.
Publicado: (2002)

Humanization and directed evolution of the selenium-containing scFv phage abzyme
por: Xu, Yan, et al.
Publicado: (2018)

Engineered Human Monoclonal scFv to Receptor Binding Domain of Ebolavirus
por: Densumite, Jaslan, et al.
Publicado: (2021)

Isolation and Characterization of Novel Phage Displayed scFv Fragment for Human Tumor Necrosis Factor Alpha and Molecular Docking Analysis of Their Interactions
por: Safarpour, Hossein, et al.
Publicado: (2018)

Periplasmic Expression of a Novel Human Bone Morphogenetic Protein-7 Mutant in Escherichia coli
por: Nematollahi, Leila, et al.
Publicado: (2012)

Relative Contribution of Framework and CDR Regions in Antibody Variable Domains to Multimerisation of Fv- and scFv-Containing Bispecific Antibodies
por: Bhatta, Pallavi, et al.
Publicado: (2018)

Production and characterisation of a recombinant scFv reactive with human gastrointestinal carcinomas
por: Kim, D-J, et al.
Publicado: (2002)

Generation and Characterization of an scFv Directed against Site II of Rabies Glycoprotein
por: Aavula, Shukra M., et al.
Publicado: (2011)

Production of scFv-Conjugated Affinity Silk Powder by Transgenic Silkworm Technology
por: Sato, Mitsuru, et al.
Publicado: (2012)

Early Detection of NSCLC with scFv Selected against IgM Autoantibody
por: Pedchenko, Tetyana, et al.
Publicado: (2013)

Development and identification of fully human scFv-Fcs against Staphylococcus aureus
por: Nian, Siji, et al.
Publicado: (2016)

Development of Human-Like scFv-Fc Neutralizing Botulinum Neurotoxin E
por: Miethe, Sebastian, et al.
Publicado: (2015)

Targeting scFv-Fc-scTRAIL fusion proteins to tumor cells
por: Hutt, Meike, et al.
Publicado: (2018)

Targeting HER2-breast tumors with scFv-decorated bimodal nanoprobes
por: Alric, Christophe, et al.
Publicado: (2018)

Generation of a Fully Human scFv that binds Tumor-Specific Glycoforms
por: Lu, Zhongpeng, et al.
Publicado: (2019)

Characterization and analysis of scFv-IgG bispecific antibody size variants
por: Cao, Mingyan, et al.
Publicado: (2018)

Development and in vitro characterization of a humanized scFv against fungal infections
por: Di Mambro, Tomas, et al.
Publicado: (2022)

Bioinformatics in molecular immunology laboratories demonstrated: Modeling an anti-CMV scFv antibody
por: Heng, Chua Kek, et al.
Publicado: (2006)

Bacterial secretion of soluble and functional trivalent scFv-based N-terminal trimerbodies
por: Blanco-Toribio, Ana, et al.
Publicado: (2015)

Refolded scFv Antibody Fragment against Myoglobin Shows Rapid Reaction Kinetics
por: Song, Hyung-Nam, et al.
Publicado: (2014)

Cell-free eukaryotic systems for the production, engineering, and modification of scFv antibody fragments
por: Stech, Marlitt, et al.
Publicado: (2014)

A Novel Human scFv Library with Non-Combinatorial Synthetic CDR Diversity
por: Bai, Xuelian, et al.
Publicado: (2015)

Generation and characterization of a novel recombinant scFv antibody specific for Campylobacter jejuni
por: Nzuma, Ruramayi M., et al.
Publicado: (2018)

Isolation and identification of an scFv antibody against nucleocapsid protein of SARS-CoV
por: Zhao, Aizhi, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_15l39i0acqjug3n1varvmuq1ce